Biotech GBT Initiates Expanded Access Program for Voxelotor in Patients With Sickle Cell Disease in Brazil July 25, 2022
Biotech UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) Supports Expedited Review of Marketing Authorization Application for Sabizabulin Treatment in Hospitalized COVID-19 Patients July 25, 2022
Biotech Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) July 25, 2022